160765-31-1

Basic information

• Product Name: D-2-O-benzyl-6-deoxy-myo-inositol
• Synonyms: D-2-O-benzyl-6-deoxy-myo-inositol
• CAS NO: 160765-31-1
• Molecular Weight: 254.283
• Mol File: 160765-31-1.mol

Chemical Properties

• CAS DataBase Reference: D-2-O-benzyl-6-deoxy-myo-inositol(CAS DataBase Reference)
• NIST Chemistry Reference: D-2-O-benzyl-6-deoxy-myo-inositol(160765-31-1)
• EPA Substance Registry System: D-2-O-benzyl-6-deoxy-myo-inositol(160765-31-1)

Safety Data

• Hazardous Substances Data: 160765-31-1(Hazardous Substances Data)

Upstream product

• 229172-85-4 D-1,4,5-tri-O-benzoyl-2-O-benzyl-6-deoxy-3-O-trimethylacetyl-myo-inositol 
• 328379-91-5 D-2-O-Benzyl-6-deoxy-1,3,4,5-tetra-O-p-methoxybenzyl-myo-inositol 
• 328379-87-9 D-6-Deoxy-1,4,5-tri-O-p-methoxybenzyl-myo-inositol 
• 328379-89-1 D-6-Deoxy-1,3,4,5-tetra-O-p-methoxybenzyl-myo-inositol 
• 229172-82-1 D-1,4,5-tri-O-benzoyl-2,3-O-cyclohexylidene-6-deoxy-myo-inositol 
• 229172-84-3 D-1,4,5-tri-O-benzoyl-6-deoxy-3-O-trimethylacetyl-myo-inositol 
• 229172-83-2 D-1,4,5-tri-O-benzoyl-6-deoxy-myo-inositol 
• 156712-80-0 3,4-O-cyclohexylidene-6-deoxy-myo-inositol 
• 4257-83-4 benzyl 2,2,2-trichloroacetamide 
• 328379-85-7 D-3-O-[S-(+)-O-Acetylmandelyl]-6-deoxy-1,4,5-tri-O-p-methoxybenzyl-myo-inositol 

Downstream Products

• 160765-13-9 D-2-O-Benzyl-1,3,4,5-tetrakis[bis(benzyloxy)phospho]-6-deoxy-myo-inositol 

Relevant articles and documents

Synthesis of the enantiomers of 6-deoxy-myo-inositol 1,3,4,5-Tetrakisphosphate, structural analogues of myo-inositol 1,3,4,5-Tetrakisphosphate

D-myo-Inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] is produced rapidly from the established second messenger D-myo-inositol 1,4,5trisphosphate [Ins(1,4,5)P4] in stimulated cells. Despite extensive investigations, in particular

Stereoselective synthesis of myo-inositol-1,3,4,5-tetrakisphosphate analoques from 6-deoxy D-inositol precursors

The synthesis of 6-deoxy-D-myo-inositol-1,3,4,5-tetrakisphosphates is described. The access to opticaly pure Ins(1.3.4.5)P4 analogues was carried out from deoxy myo inositol precursors derived from D-galactose. Modification of Ins(1,3,4,5)P4 analogues by lipophilic substituents has been investigated in order to produce neutral phosphate derivatives aimed to be incorporated in cell membrane for in vivo evaluation.